Academic Journal

719TiP A phase I/Ib study of the Werner (WRN) helicase inhibitor HRO761 as single agent and in combination with irinotecan or tislelizumab in patients with microsatellite instability-high (MSIhi) or mismatch repair deficient (dMMR) advanced solid tumors

التفاصيل البيبلوغرافية
العنوان: 719TiP A phase I/Ib study of the Werner (WRN) helicase inhibitor HRO761 as single agent and in combination with irinotecan or tislelizumab in patients with microsatellite instability-high (MSIhi) or mismatch repair deficient (dMMR) advanced solid tumors
المؤلفون: Moschetta, M., Doi, T., Kuboki, Y., Sundar, R., Möbitz, H., Jaco, I., Cortes Cros, M., Ferretti, S., Jankovic, D., Thérier, M., Clementi, G., Li, Y., De Kanter, R., Quadt, C.
المصدر: Annals of Oncology ; volume 34, page S496 ; ISSN 0923-7534
بيانات النشر: Elsevier BV
سنة النشر: 2023
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.annonc.2023.09.1905
الاتاحة: http://dx.doi.org/10.1016/j.annonc.2023.09.1905
https://api.elsevier.com/content/article/PII:S0923753423027424?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753423027424?httpAccept=text/plain
Rights: https://www.elsevier.com/tdm/userlicense/1.0/
رقم الانضمام: edsbas.9570A8A
قاعدة البيانات: BASE
الوصف
DOI:10.1016/j.annonc.2023.09.1905